Patents by Inventor Agnes E. PAL

Agnes E. PAL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystaline forms of HCV inhibitor
    Patent number: 9469673
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern at values of two theta (° 2?) of 10.7, 11.6, 12.7, 13.0, 13.2, 13.7, 14.5, 18.7, 19.0, and 19.9 after equilibration at 43% relative humidity.
    Type: Grant
    Filed: July 11, 2013
    Date of Patent: October 18, 2016
    Assignee: AbbVie Inc.
    Inventors: Ahmad Y. Sheikh, Moiz Diwan, Agnes E. Pal, Yuchuan Gong, Paul J. Brackemeyer, Geoff Zhang, Seble Wagaw
  • CRYSTAL FORMS
    Publication number: 20150175612
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern at values of two theta (°2?) of 6.0, 6.7, 10.4, 11.9, 17.5, 17.7, 21.5, 22.0, 22.7, and 24.2.
    Type: Application
    Filed: December 3, 2014
    Publication date: June 25, 2015
    Applicant: AbbVie Inc.
    Inventors: Paul J. Brackemeyer, Moiz Diwan, Yuchuan Gong, Agnes E. Pal, Ahmad Y. Sheikh, Seble H. Wagaw, Geoff G. Zhang
  • CRYSTALINE FORMS OF HCV INHIBITOR
    Publication number: 20140018518
    Abstract: The present invention features crystalline forms of Compound I. In one embodiment, a crystalline form of Compound I has characteristic peaks in the PXRD pattern at values of two theta (° 2?) of 10.7, 11.6, 12.7, 13.0, 13.2, 13.7, 14.5, 18.7, 19.0, and 19.9 after equilibration at 43% relative humidity.
    Type: Application
    Filed: July 11, 2013
    Publication date: January 16, 2014
    Inventors: Ahmad Y. SHEIKH, Moiz DIWAN, Agnes E. PAL, Yuchuan GONG, Paul J. BRACKEMEYER, Geoff ZHANG, Seble WAGAW